Insiders · Profile

VAGELOS P ROY

Director at Regeneron Pharmaceuticals · Director at Innoviva. Filing since 13 Mar 2008. CIK 0001013064

Company
Date
Role
Action
Shares
Amount
Of holding
30 Mar 2022
Director
Sold, plan not stated
28,572
$20.00M
54.9%
18 Aug 2021
Director
Sold, plan not stated
10,039
$6.53M
21.0%
11 Aug 2020
Director
Sold, plan not stated
33,460
$20.17M
40.0%
21 May 2020
Chairman of the Board
Sold, plan not stated
149,594
$84.44M
32.7%
13 Dec 2019
Chairman of the Board
Sold, plan not stated
51,842
$19.49M
14.5%
25 Nov 2019
Chairman of the Board
Sold, plan not stated
22,149
$8.06M
6.8%
12 Dec 2018
Chairman of the Board
Sold, plan not stated
6
$2.29K
0.3%
10 Jul 2018
Chairman of the Board
Sold, plan not stated
74,670
$27.42M
15.7%
21 Jun 2018
Chairman of the Board
Sold, plan not stated
74,710
$24.50M
15.7%
22 Aug 2017
Chairman of the Board
Sold, plan not stated
31,944
$15.26M
8.8%
21 Aug 2017
Chairman of the Board
Sold, plan not stated
24,269
$11.41M
6.3%
18 Aug 2017
Chairman of the Board
Sold, plan not stated
2,900
$1.36M
0.7%
17 Aug 2017
Chairman of the Board
Sold, plan not stated
1,305
$613.35K
0.3%
16 Aug 2017
Chairman of the Board
Sold, plan not stated
10,986
$5.17M
2.7%
25 May 2017
Chairman of the Board
Sold, plan not stated
9,295
$4.26M
10.0%
18 Nov 2015
Chairman of the Board
Sold, plan not stated
17,240
$10.14M
4.9%
3 Nov 2015
Chairman of the Board
Sold, plan not stated
3,985
$2.31M
1.1%
2 Nov 2015
Chairman of the Board
Sold, plan not stated
13,257
$7.69M
3.6%
10 Sep 2014
Chairman of the Board
Sold, plan not stated
10,326
$3.61M
10.0%
8 Sep 2014
Chairman of the Board
Sold, plan not stated
2
$702.00
0.0%
13 Aug 2014
Chairman of the Board
Sold, plan not stated
8,028
$2.73M
3.1%
11 Aug 2014
Chairman of the Board
Sold, plan not stated
9,372
$3.19M
3.5%
8 Aug 2014
Chairman of the Board
Sold, plan not stated
2,600
$884.86K
1.0%
11 Feb 2014
Chairman of the Board
Sold, plan not stated
11,475
$3.73M
10.0%
2 Dec 2013
Chairman of the Board
Sold, plan not stated
95
$28.13K
4.0%
19 Sep 2013
Chairman of the Board
Sold, plan not stated
145,356
$44.02M
68.9%
6 May 2013
Chairman of the Board
Sold, plan not stated
13,482
$3.55M
10.6%
29 Nov 2012
Chairman of the Board
Sold, plan not stated
78,630
$14.11M
58.0%
28 Nov 2012
Chairman of the Board
Sold, plan not stated
7,004
$1.23M
4.9%
27 Nov 2012
Chairman of the Board
Sold, plan not stated
36,246
$6.35M
20.3%
26 Nov 2012
Chairman of the Board
Sold, plan not stated
28,507
$4.99M
13.7%
19 Nov 2012
Chairman of the Board
Sold, plan not stated
32,500
$5.22M
20.3%
2 Sep 2011
Chairman of the Board
Sold, plan not stated
88,955
$5.44M
38.8%
1 Sep 2011
Chairman of the Board
Sold, plan not stated
3,500
$210.00K
1.5%
14 Jul 2011
Chairman of the Board
Sold, plan not stated
658
$37.31K
0.4%
13 Jul 2011
Chairman of the Board
Sold, plan not stated
25,935
$1.48M
13.9%
12 Jul 2011
Chairman of the Board
Sold, plan not stated
23,635
$1.35M
11.2%
11 Jul 2011
Chairman of the Board
Sold, plan not stated
24,772
$1.43M
10.5%
6 Jan 2011
Director
Sold, plan not stated
21,043
$716.30K
16.0%
3 Jan 2011
Director
Sold, plan not stated
8,957
$304.90K
6.4%
17 Dec 2010
Director
Sold, plan not stated
12,616
$404.47K
8.2%
16 Dec 2010
Director
Sold, plan not stated
17,384
$556.98K
10.2%
23 Nov 2010
Director
Sold, plan not stated
30,000
$900.90K
15.0%
14 May 2010
Director
Sold, plan not stated
20,000
$543.20K
3.6%
14 Mar 2008
Director
Bought
25,000
$255.84K
53.8%
13 Mar 2008
Director
Bought
24,000
$252.85K
107%
46 decisions on file.